Magnet and wire remodeling for the treatment of candy cane syndrome: first case series of a new approach (with video).
Ricardo Rio-Tinto, François Huberland, Pauline Van Ouytsel...
https://pubmed.ncbi.nlm.nih.gov/34979115/Actively Recruiting
Led by Erasme University Hospital · Updated on 2023-11-18
51
Participants Needed
1
Research Sites
N/A
Total Duration
Candy cane syndrome CCS is a complication that can happen after stomach surgery like gastrectomy or gastric bypass, where a part of the intestine enlarges and causes symptoms such as pain, nausea, vomiting, fullness, reflux, weight loss, and difficulty eating. This syndrome is mainly mechanical and can lead to serious problems like cachexia. Researchers are evaluating a new medical device called MAGUS to treat CCS in a less invasive way compared to the current surgical option, which can have significant risks and only moderate success. This study aims to assess the safety and effectiveness of this device in patients with CCS. The treatment involves placing the MAGUS device inside the digestive tract using an endoscopic procedure under general anesthesia with fluoroscopic guidance. The device works by using magnets to create pressure necrosis and open the blind loop within about 30 days. This study will enroll 51 patients at a single center, and the device placement will be carefully monitored with imaging before and after the procedure. Follow-up visits will occur at 14 days, 28 days, 3 months, and 12 months after treatment. Participants will undergo physical exams, medical history reviews, symptom scoring, and quality of life questionnaires both before and after the device placement. Imaging tests such as barium swallow X-rays or endoscopic assessments will be used to evaluate the blind loop. Researchers will track safety by monitoring adverse events throughout the study and assess how symptoms change over time. The study will last up to 12 months post-procedure, with a 3-year enrollment period, to fully understand the devices performance and patient satisfaction.
CONDITIONS
Evaluation of the Performance of MAgnetic Gastrointestinal Universal Septotome for Treatment of Candy Cane Syndrome
P
Pauline Van Ouytsel
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Erasme University Hospital
Lead Sponsor
Brussel Medical Device Center (BMDC)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day (operative day)
Participants receive the MAGUS device placement by endoscopy under general anesthesia with fluoroscopic control.
1 procedure visit (in-person)
Duration - Up to 12 months following the procedure
Participants are monitored for safety and symptoms evolution after device placement with visits to assess adverse events, symptom improvement, and quality of life.
Visits at 14 days, 28 days, 3 months, and 12 months (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Ricardo Rio-Tinto, François Huberland, Pauline Van Ouytsel...
https://pubmed.ncbi.nlm.nih.gov/34979115/Erasme University Hospital
Lead Sponsor
Brussel Medical Device Center (BMDC)
Collaborating Sponsor